Understanding how blood phobia affects fainting
Impact of Blood Phobia on Fainting Susceptibility
This study is testing how a fear of blood and needles affects fainting by looking at how people's bodies respond when they feel stressed about these things.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Simon Fraser University Academic / other |
| Locations | 1 site (Burnaby, British Columbia) |
| Trial ID | NCT06336031 on ClinicalTrials.gov |
What this trial studies
This study aims to explore the relationship between blood-injection-injury phobia and fainting susceptibility by assessing cardiovascular autonomic function during an orthostatic challenge. Participants, both with and without known needle phobia, will undergo a tilt test to evaluate their cardiovascular reflex control in response to emotional stimuli related to their phobia. The study seeks to fill the gap in understanding how emotional stress triggers hypotensive reactions that can lead to vasovagal syncope. By characterizing these responses, the research hopes to shed light on the public health implications of this phobia and its impact on healthcare avoidance behaviors.
Who should consider this trial
Good fit: Ideal candidates for this study are English-speaking adults aged 18 to 50, both those with and without suspected blood-injection-injury phobia.
Not a fit: Patients with diagnosed cardiovascular or neurological disorders, those who are menopausal, pregnant, or taking cardiovascular medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management strategies for individuals with blood phobia, reducing their risk of fainting and improving their willingness to undergo necessary medical procedures.
How similar studies have performed: While there is limited literature on this specific approach, studies have shown that understanding the physiological responses to phobias can lead to improved treatment strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * male and female * 18 to 50 years old * those without a suspected BII fear and those with a suspected fear * english speaking Exclusion Criteria: * diagnosis of any cardiovacular or neurological disorder * menopausal * taking medication for a cardiovascular condition * if they are pregnant
Where this trial is running
Burnaby, British Columbia
- Simon Fraser University — Burnaby, British Columbia, Canada (Recruiting)
Study contacts
- Principal investigator: Victoria E Claydon, PhD — Professor, Biomedical Physiology and Kinesiology
- Study coordinator: Victoria E Claydon, PhD
- Email: victoria_claydon@sfu.ca
- Phone: 7787828513
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.